PRO 07 - Management of Melanoma and Merkel Cell Carcinoma: Immunotherapy and its Impact on Radiation Decision Making
MODERATOR(S)
Benjamin Moeller, MD, PhD - Southeast Radiation Oncology Group PA
session DESCRIPTION
Radiation management decisions for melanoma and Merkel cell carcinoma are changing rapidly as immuno-oncology reshapes the treatment of these diseases. Our expert panel will aim to give practical advice on options for these patients in the context of IO therapy. The first discussant will give a brief overview of the state of IO therapy for these diseases from the perspective of a practicing medical oncologist. The next two discussants will describe how immunotherapy has changed radiation decision making for melanoma and Merkel cell carcinoma.
learning objectives
- Describe the current role for IO in the management of melanoma and Merkel cell carcinoma.
- Describe when and how IO-treated melanoma and Merkel cell carcinoma patients should be treated with radiation.
Credits
| AMA PRA Category 1 Credits: | 1.25 |
Presentations
-
05:00pm - 05:02pm ETSpeaker: Benjamin Moeller, MD, PhD - Southeast Radiation Oncology Group PA, Charlotte
-
05:02pm - 05:22pm ETSpeaker: Jennifer Atlas, MD - Levine Cancer Institute, Charlotte
-
05:22pm - 05:42pm ETSpeaker: Anna Likhacheva, MD, MPH - Sutter Medical Group, Sacramento
-
05:42pm - 06:02pm ETSpeaker: Benjamin Moeller, MD, PhD - Southeast Radiation Oncology Group PA, Charlotte
-
06:02pm - 06:15pm ETSpeaker: Benjamin Moeller, MD, PhD - Southeast Radiation Oncology Group PA, Charlotte